Evidence map›Paper›PMID 32886303›Full record

ArticleMolecular imaging and biology2021

Development and Preclinical Evaluation of

George Makris, Rajendra P Bandari, Marina Kuchuk, Silvia S Jurisson, Charles J Smith, Heather M Hennkens

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. [ACS omega · 2024
    Article
  5. Article
  6. Optimization of the Pharmacokinetic Profile of [Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

George MakrisResearch Reactor Center, University of Missouri, Columbia, MO, 65211, USA.
Rajendra P BandariResearch Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, 65201, USA.
Marina KuchukResearch Reactor Center, University of Missouri, Columbia, MO, 65211, USA.
Silvia S JurissonDepartment of Chemistry, University of Missouri, Columbia, MO, 65211, USA.
Charles J SmithResearch Reactor Center, University of Missouri, Columbia, MO, 65211, USA.
Heather M HennkensResearch Reactor Center, University of Missouri, Columbia, MO, 65211, USA. HennkensH@missouri.edu.ORCID 0000-0002-3283-8751
University of Missouri · USHarry S. Truman Memorial Veterans' Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe goal of this work was to develop hydrophilic gastrin-releasing peptide receptor (GRPR)-targeting complexes of the general formula fac-[M(CO) PROCEDURES: Metallated-peptides were prepared employing the [M(OH

resultsHigh in vitro receptor affinity (IC

conclusions[

Indexed as

AcetatesAnimalsHeterocyclic Compounds, 1-RingInhibitory Concentration 50LigandsMiceMice, SCIDNeoplasmsPeptidesRadioisotopesReceptors, BombesinRheniumSingle Photon Emission Computed Tomography Computed TomographyTechnetiumTissue DistributionWhole Body Imaging1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane1,4,7-triazacyclononane-N,N',N''-triacetic acidAcetatesHeterocyclic Compounds, 1-RingLigandsPeptidesRadioisotopesReceptors, BombesinRheniumRhenium-186TechnetiumGastrin-releasing peptide receptorMicro-SPECT/CT imagingOrganometallic complexesProstate cancerRhenium-186Technetium-99mTheranosticsTricarbonyl complexes

Identifiers

PMID32886303
OpenAlexW3083147543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.